● DAMMNEWS STORY INTEL • ROUTE A LOCAL/FREE • NO PAID AI API ●
DAMMNEWS®
Independent aggregation • v2.4.14 • 2026-08-06

KALSHI AND POLYMARKET BETS ON CLINICAL TRIALS CRITICIZED AS 'GHASTLY'

1 min read • 1 hr ago • NPR Topics: News • [src]
SOURCE SPECTRUM: NPR Lean Left
LEFTCENTRERIGHT
Third-party classification: AllSidesmethod and full source list. Bias is not a truth score.
REPORT A PROBLEM WITH THIS SOURCE
Reports are reviewed by the DAMMNEWS administrator. Please do not include personal or sensitive information.

SOURCE AGREEMENT & OPEN QUESTIONS

WHAT SOURCES AGREE ON
One linked publisher is currently carrying this report in the live cache.

WHAT REMAINS UNCLEAR
RSS excerpts are short and may omit qualifications, timing or attribution. Read the original reports before treating a detail as settled.

WHERE REPORTING MAY DIFFER
Independent comparison coverage has not yet been identified in the current live cache.

SOURCE COMPARISON

SourceLatest linked headlineAge
NPR Topics: NewsKALSHI AND POLYMARKET BETS ON CLINICAL TRIALS CRITICIZED AS 'GHASTLY'1 hr ago

WHAT HAPPENED

Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.

NPR Topics: News reports that researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development.

The report adds: But Kalshi and Polymarket say they provide valuable information to patients.

This is a developing report. DAMMNEWS will surface related coverage as closely matched reporting enters the live cache.

DAMMNEWS RSS BRIEFING — generated locally from the available NPR Topics: News headline and RSS excerpt. It is not a summary of the full source article.

ADVERTISEMENT

RELATED DAMMNEWS COVERAGE

Built locally from the available RSS excerpts for this story and closely related DAMMNEWS coverage. Statements are attributed to their feed source; no paid AI API was used. Short excerpts can omit important context, so the original source remains essential.
READ FULL AT SOURCE →
ADVERTISEMENT
TEXT MODE PRINT SHARE: X Facebook Email ← Front page
ADVERTISEMENT
DAMMNEWS® 2026 • Local rules-based story intelligence • Original source remains one click away
RSSSource SpectrumAboutPrivacyContactTerms